Nitric oxide (NO) plays an important anti-apoptotic role by inactivating bo
th upstream and downstream apoptotic molecules. We now report that exogenou
sly supplied NO protected Jurkat T cells from anti-CD95-stimulated apoptosi
s. WE have recently shown that nitrosation of the activator protein-1 (AP-1
) transcriptional factor is crucial for NO-mediated inhibition of cell deat
h triggered by etoposide or ceramide. Since the inhibition of apoptosis by
NO has been reported to involve AP-1, we evaluated its involvement in in CD
95-mediated cell death. Cross-linking of CD95 enhanced AP-1 DNA binding act
ivity and AP-l-dependent CD95L transactivation, which were both significant
ly reduced by different NO-donors compounds. However, AP-1 induction does n
ot seem to significantly contribute to anti-wCD95-triggered apoptosis, as c
ell death could not be prevented by using the recombinant Fas-fc fusion pro
tein which inhibits the CD95/CD95L interaction. We observed that caspase 3-
like activity was negatively modulated by several NO-donors in vitro and th
at titratable thiol groups of purified caspases 3, 7, and 9 decreased in th
e presence of NO-releasing compounds. In conclusion, we demonstrated that N
O-mediated inhibition of other targets, possibly caspases, but not AP-1, is
a crucial event responsible for protection against anti-CD95-stimulated ap
optosis. Even though NO affects multiple molecular mechanisms, the relevant
target for exerting the cellular effects, may vary among different models.